Hokey, why do you keep on repeating the false information that "A2m milk is not unique as all milk contains the A2 protein"?
A2 milk IS absolutely unique because it is the only cows milk on the market that excludes the hazardous A1 protein.
By suggesting that other milks are similarly beneficial because they contain some A2 protein, you are knowingly misleading investors. You are doing this in two ways.
Firstly you are propagating the false notion that A2 milk is essentially the same as other brands of cows milk and therefore a2MC has no real advantage. That could adversely affect readers' investment decisions.
And secondly you are promoting a false understanding of the health implications concerning the A1 protein. That could adversely affect readers' consumer health decisions.
And you know that you are doing this. It is a repeated and deliberately misleading ploy on your part.
It is an outright falsehood to suggest that Pura and the other brands that boast they contain SOME A2 protein can claim the same health advantages as a2MC. They are just trying to mislead the consumer public by diverting attention away from the unwelcome fact that they contain A1, which can lead to the creation in the body of the harmful peptide BCM7.
BCM7 is implicated in neurological diseases such as autism and schizophrenia as well as the milk intolerance that affects many consumers. New research indicates it is also likely to be a factor in other diseases and conditions including sudden infant death.
These facts are clearly documented in recent research papers published in refereed scientific journals, which I have cited previously on this forum and you are well aware of them. They are not disputed in the scientific community.
- Forums
- ASX - By Stock
- A2M
- TA price target 1.06 A2M
TA price target 1.06 A2M, page-186
-
- There are more pages in this discussion • 872 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.92 |
Change
0.110(2.29%) |
Mkt cap ! $3.536B |
Open | High | Low | Value | Volume |
$4.82 | $4.94 | $4.79 | $10.09M | 2.061M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4318 | $4.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.92 | 42416 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 62727 | 5.450 |
1 | 45457 | 5.290 |
1 | 1825 | 5.280 |
3 | 6401 | 5.240 |
1 | 22136 | 5.200 |
Price($) | Vol. | No. |
---|---|---|
4.510 | 226 | 1 |
4.630 | 68000 | 1 |
4.640 | 49968 | 9 |
4.650 | 14743 | 3 |
4.660 | 1478 | 2 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online